We found that ex vivo stimulation led to a significant decrease in the median proportion of CLL cells expressing the CTLA-4 molecule on their surface, which became comparable to the value of the corresponding cells in healthy individuals. The gene discussed is CTLA4; the disease is B-cell chronic lymphocytic leukemia.